Alessi, D.R., Sakamoto, K., and Bayascas, J.R. (2006). LKB1-dependent
signaling pathways. Annu. Rev. Biochem. 75, 137–163.
Backer, J.M. (2008). The regulation and function of Class III PI3Ks: novel roles
for Vps34. Biochem. J. 410, 1–17.
Bassel-Duby, R., and Olson, E.N. (2006). Signaling pathways in skeletal
muscle remodeling. Annu. Rev. Biochem. 75, 19–37.
Bastie, C.C., Zong, H., Xu, J., Busa, B., Judex, S., Kurland, I.J., and Pessin,
J.E. (2007). Integrative metabolic regulation of peripheral tissue fatty acid
oxidation by the SRC kinase family member Fyn. Cell Metab. 5, 371–381.
Bechet, D., Tassa, A., Taillandier, D., Combaret, L., and Attaix, D. (2005).
Lysosomal proteolysis in skeletal muscle. Int. J. Biochem. Cell Biol. 37,
2098–2114.
Bentzinger, C.F., Romanino, K., Cloe¨ tta, D., Lin, S., Mascarenhas, J.B., Oliveri,
F., Xia, J., Casanova, E., Costa, C.F., Brink, M., et al. (2008). Skeletal musclespecific
ablation of raptor, but not of rictor, causes metabolic changes and
results in muscle dystrophy. Cell Metab. 8, 411–424.
Brignatz, C., Paronetto, M.P., Opi, S., Cappellari, M., Audebert, S., Feuillet, V.,
Bismuth, G., Roche, S., Arold, S.T., Sette, C., and Collette, Y. (2009). Alternative
splicing modulates autoinhibition and SH3 accessibility in the Src kinase
Fyn. Mol. Cell. Biol. 29, 6438–6448.
Chiacchiera, F., and Simone, C. (2010). The AMPK-FoxO3A axis as a target for
cancer treatment. Cell Cycle 9, 1091–1096.
Cooke, M.P., and Perlmutter, R.M. (1989). Expression of a novel form of the fyn
proto-oncogene in hematopoietic cells. New Biol. 1, 66–74.
Davidson, D., Viallet, J., and Veillette, A. (1994). Unique catalytic properties
dictate the enhanced function of p59fynT, the hemopoietic cell-specific
isoform of the Fyn tyrosine protein kinase, in T cells. Mol. Cell. Biol. 14,
4554–4564.
Egan, D.F., Shackelford, D.B., Mihaylova, M.M., Gelino, S., Kohnz, R.A., Mair,
W., Vasquez, D.S., Joshi, A., Gwinn, D.M., Taylor, R., et al. (2011). Phosphorylation
of ULK1 (hATG1) by AMP-activated protein kinase connects energy
sensing to mitophagy. Science 331, 456–461.
Funderburk, S.F., Wang, Q.J., and Yue, Z. (2010). The Beclin 1-VPS34
complex—at the crossroads of autophagy and beyond. Trends Cell Biol. 20,
355–362.
Greer, E.L., Oskoui, P.R., Banko, M.R., Maniar, J.M., Gygi, M.P., Gygi, S.P.,
and Brunet, A. (2007). The energy sensor AMP-activated protein kinase
directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem.
282, 30107–30119.
Grumati, P., Coletto, L., Sabatelli, P., Cescon, M., Angelin, A., Bertaggia, E.,
Blaauw, B., Urciuolo, A., Tiepolo, T., Merlini, L., et al. (2010). Autophagy is
defective in collagen VI muscular dystrophies, and its reactivation rescues
myofiber degeneration. Nat. Med. 16, 1313–1320.
Hardie, D.G. (2011). AMP-activated protein kinase: a cellular energy sensor
with a key role in metabolic disorders and in cancer. Biochem. Soc. Trans.
39, 1–13.
He, C., and Klionsky, D.J. (2009). Regulation mechanisms and signaling pathways
of autophagy. Annu. Rev. Genet. 43, 67–93.
Howell, J.J., and Manning, B.D. (2011). mTOR couples cellular nutrient sensing
to organismal metabolic homeostasis. Trends Endocrinol. Metab. 22, 94–102.
Itakura, E., and Mizushima, N. (2009). Atg14 and UVRAG: mutually exclusive
subunits of mammalian Beclin 1-PI3K complexes. Autophagy 5, 534–536.
Jansen, M., Ten Klooster, J.P., Offerhaus, G.J., and Clevers, H. (2009). LKB1
and AMPK family signaling: the intimate link between cell polarity and energy
metabolism. Physiol. Rev. 89, 777–798.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T.,
Kominami, E., Ohsumi, Y., and Yoshimori, T. (2000). LC3, a mammalian homologue
of yeast Apg8p, is localized in autophagosome membranes after processing.
EMBO J. 19, 5720–5728.
Kazi, A.A., Hong-Brown, L., Lang, S.M., and Lang, C.H. (2011). Deptor knockdown
enhances mTOR Activity and protein synthesis in myocytes and ameliorates
disuse muscle atrophy. Mol. Med. 17, 925–936.
Khan, A.H., Thurmond, D.C., Yang, C., Ceresa, B.P., Sigmund, C.D., and
Pessin, J.E. (2001). Munc18c regulates insulin-stimulated glut4 translocation
to the transverse tubules in skeletal muscle. J. Biol. Chem. 276, 4063–4069.
Kim, J., Kundu, M., Viollet, B., and Guan, K.L. (2011). AMPK and mTOR
regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol.
13, 132–141.
Kimball, S.R. (2006). Interaction between the AMP-activated protein kinase
and mTOR signaling pathways. Med. Sci. Sports Exerc. 38, 1958–1964.
Klionsky, D.J., Abeliovich, H., Agostinis, P., Agrawal, D.K., Aliev, G., Askew,
D.S., Baba, M., Baehrecke, E.H., Bahr, B.A., Ballabio, A., et al. (2008). Guidelines
for the use and interpretation of assays for monitoring autophagy in higher
eukaryotes. Autophagy 4, 151–175.
Koga, H., Kaushik, S., and Cuervo, A.M. (2010). Altered lipid content inhibits
autophagic vesicular fusion. FASEB J. 24, 3052–3065.
Lage, R., Die´ guez, C., Vidal-Puig, A., and Lo´ pez, M. (2008). AMPK: a metabolic
gauge regulating whole-body energy homeostasis. Trends Mol. Med. 14,
539–549.
Lantier, L., Mounier, R., Leclerc, J., Pende, M., Foretz, M., and Viollet, B.
(2010). Coordinated maintenance of muscle cell size control by AMP-activated
protein kinase. FASEB J. 24, 3555–3561.
Lee, C.H., Inoki, K., and Guan, K.L. (2007). mTOR pathway as a target in tissue
hypertrophy. Annu. Rev. Pharmacol. Toxicol. 47, 443–467.
Long, Y.C., and Zierath, J.R. (2006). AMP-activated protein kinase signaling in
metabolic regulation. J. Clin. Invest. 116, 1776–1783.
Luo, Z., Saha, A.K., Xiang, X., and Ruderman, N.B. (2005). AMPK, the metabolic
syndrome and cancer. Trends Pharmacol. Sci. 26, 69–76.
Malicdan, M.C., Noguchi, S., and Nishino, I. (2009). Monitoring autophagy in
muscle diseases. Methods Enzymol. 453, 379–396.
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo,
P., Burden, S.J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007). FoxO3 controls
autophagy in skeletal muscle in vivo. Cell Metab. 6, 458–471.
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M.,
Metzger, D., Reggiani, C., Schiaffino, S., and Sandri, M. (2009). Autophagy
is required to maintain muscle mass. Cell Metab. 10, 507–515.
Mizushima, N. (2010). The role of the Atg1/ULK1 complex in autophagy regulation.
Curr. Opin. Cell Biol. 22, 132–139.
Mizushima, N., Yoshimori, T., and Levine, B. (2010). Methods in mammalian
autophagy research. Cell 140, 313–326.
Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Pende, M., Daegelen, D.,
Sakamoto, K., Foretz, M., and Viollet, B. (2009). Important role for AMPKalpha1
in limiting skeletal muscle cell hypertrophy. FASEB J. 23, 2264–2273.
Noda, T., Matsunaga, K., Taguchi-Atarashi, N., and Yoshimori, T. (2010).
Regulation of membrane biogenesis in autophagy via PI3P dynamics. Semin.
Cell Dev. Biol. 21, 671–676.
Ogata, T., Oishi, Y., Higuchi, M., and Muraoka, I. (2010). Fasting-related autophagic
response in slow- and fast-twitch skeletal muscle. Biochem. Biophys.
Res. Commun. 394, 136–140.
Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E.,
and Plotz, P. (2008). Suppression of autophagy in skeletal muscle uncovers the
accumulation of ubiquitinated proteins and their potential role in muscle
damage in Pompe disease. Hum. Mol. Genet. 17, 3897–3908.
Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C.,
Richard-Bulteau, H., Vignaud, A., Baas, D., Defour, A., et al. (2009). Muscle
inactivation of mTOR causes metabolic and dystrophin defects leading to
severe myopathy. J. Cell Biol. 187, 859–874.
Saito, Y.D., Jensen, A.R., Salgia, R., and Posadas, E.M. (2010). Fyn: a novel
molecular target in cancer. Cancer 116, 1629–1637.
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S., and Sabatini,
D.M. (2010). Ragulator-Rag complex targets mTORC1 to the lysosomal
surface and is necessary for its activation by amino acids. Cell 141, 290–303.
Sandri, M. (2010). Autophagy in skeletal muscle. FEBS Lett. 584, 1411–1416.
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K.,
Schiaffino, S., Lecker, S.H., and Goldberg, A.L. (2004). Foxo transcription
factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal
muscle atrophy. Cell 117, 399–412.
Shackelford, D.B., and Shaw, R.J. (2009). The LKB1-AMPK pathway: metabolism
and growth control in tumour suppression. Nat. Rev. Cancer 9, 563–575.
Singh, R., and Cuervo, A.M. (2011). Autophagy in the cellular energetic
balance. Cell Metab. 13, 495–504.
Witczak, C.A., Sharoff, C.G., and Goodyear, L.J. (2008). AMP-activated
protein kinase in skeletal muscle: from structure and localization to its role
as a master regulator of cellular metabolism. Cell. Mol. Life Sci. 65, 3737–3755.
Yamada, E., Pessin, J.E., Kurland, I.J., Schwartz, G.J., and Bastie, C.C. (2010).
Fyn-dependent regulation of energy expenditure and body weight is mediated
by tyrosine phosphorylation of LKB1. Cell Metab. 11, 113–124.
Zhao, J., Brault, J.J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker,
S.H., and Goldberg, A.L. (2007). FoxO3 coordinately activates protein degradation
by the autophagic/lysosomal and proteasomal pathways in atrophying
muscle cells. Cell Metab. 6, 472–483.